2nd generation anti-androgens and radiotherapy for localized prostate cancer Journal Article

  


Authors: Charas, T.; McBride, S.
Article Title: 2nd generation anti-androgens and radiotherapy for localized prostate cancer
Abstract: Combining radiotherapy and androgen deprivation therapy is the current backbone of localized prostate cancer treatments. Recently, new agents have been used in the settings of metastatic and high risk prostate cancer, and more data is emerging showing promising results when combining these new drugs with radiotherapy. © Translational Cancer Research.
Keywords: prostate cancer; abiraterone; radiotherapy (rt); androgen deprivation therapy (adt)
Journal Title: Translational Cancer Research
Volume: 7
Issue: Suppl. 6
ISSN: 2218-676X
Publisher: Pioneer Bioscience Publishing Company  
Date Published: 2018-07-01
Start Page: S690
End Page: S694
Language: English
DOI: 10.21037/tcr.2018.05.38
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050687942&doi=10.21037%2ftcr.2018.05.38&partnerID=40&md5=c237e0bc85e8f6b16b07ac7d62b622e5
Notes: Review -- Export Date: 4 September 2018 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Sean Matthew McBride
    293 McBride
  2. Tomer Menahem Charas
    9 Charas
Related MSK Work